Inequalities in CAR T-cell therapy access for US patients with relapsed/refractory DLBCL: a SEER-Medicare data analysis.
- DOI
- 10.1182/bloodadvances.2024015634
- Published
- 2025 Sep 23
- Container
- Blood advances
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1182/bloodadvances.2024015634,
title = {Inequalities in CAR T-cell therapy access for US patients with relapsed/refractory DLBCL: a SEER-Medicare data analysis.},
author = {Chung AP and Shafrin JT and Vadgama S and Hurley K and Perales MA and Alsfeld LC and Muthukrishnan S and Patel AR and Shah GL and Maziarz RT},
year = {2025},
journal = {Blood advances},
doi = {10.1182/bloodadvances.2024015634},
url = {https://doi.org/10.1182/bloodadvances.2024015634}
}RIS
TY - JOUR TI - Inequalities in CAR T-cell therapy access for US patients with relapsed/refractory DLBCL: a SEER-Medicare data analysis. AU - Chung AP AU - Shafrin JT AU - Vadgama S AU - Hurley K AU - Perales MA AU - Alsfeld LC AU - Muthukrishnan S AU - Patel AR AU - Shah GL AU - Maziarz RT PY - 2025 JO - Blood advances DO - 10.1182/bloodadvances.2024015634 UR - https://doi.org/10.1182/bloodadvances.2024015634 ER -
APA
AP, C., JT, S., S, V., K, H., MA, P., LC, A., S, M., AR, P., GL, S., & RT, M. (2025). Inequalities in CAR T-cell therapy access for US patients with relapsed/refractory DLBCL: a SEER-Medicare data analysis.. Blood advances. https://doi.org/10.1182/bloodadvances.2024015634
Source records
- pubmed · retrieved 2026-09-26T00:42:58.427Z
- europe-pmc · retrieved 2026-09-26T00:42:58.438Z